AUS 131/doxycycline

Drug Profile

AUS 131/doxycycline

Alternative Names: Doxycycline/AUS-131; Doxycycline/s-equol; S-equol/doxycycline

Latest Information Update: 22 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nexgen Dermatologics
  • Class
  • Mechanism of Action Estrogen receptor beta agonists; Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Acne vulgaris

Most Recent Events

  • 22 Sep 2015 No recent reports on development identified - Phase-I/II for Acne vulgaris in USA (PO)
  • 30 Nov 2010 Phase-I/II clinical trials in Acne vulgaris in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top